Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies.

Hanet MS, Jamart J, Chaves AP.

Can J Ophthalmol. 2012 Dec;47(6):493-9. doi: 10.1016/j.jcjo.2012.09.001. Review.

PMID:
23217502
2.

Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials.

McDonald EM, Ram FS, Patel DV, McGhee CN.

Br J Ophthalmol. 2014 Nov;98(11):1470-7. doi: 10.1136/bjophthalmol-2013-304660. Epub 2014 Apr 12. Review.

PMID:
24729078
3.

Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.

Shah VM, Tandon R, Satpathy G, Nayak N, Chawla B, Agarwal T, Sharma N, Titiyal JS, Vajpayee RB.

Cornea. 2010 Jul;29(7):751-7. doi: 10.1097/ICO.0b013e3181ca2ba3.

PMID:
20489580
4.

Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.

O'Brien TP, Maguire MG, Fink NE, Alfonso E, McDonnell P.

Arch Ophthalmol. 1995 Oct;113(10):1257-65.

PMID:
7575256
5.

Fluoroquinolones in the treatment of bacterial keratitis.

Bower KS, Kowalski RP, Gordon YJ.

Am J Ophthalmol. 1996 Jun;121(6):712-5.

PMID:
8644818
6.
7.

Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.

Gangopadhyay N, Daniell M, Weih L, Taylor HR.

Br J Ophthalmol. 2000 Apr;84(4):378-84.

8.

Community practice patterns for bacterial corneal ulcer evaluation and treatment.

Park J, Lee KM, Zhou H, Rabin M, Jwo K, Burton WB, Gritz DC.

Eye Contact Lens. 2015 Jan;41(1):12-8. doi: 10.1097/ICL.0000000000000059.

PMID:
25536529
9.

Monotherapy versus fortified antibiotics for bacterial keratitis.

Rosenberg JB, Gritz DC.

Cornea. 2011 Sep;30(9):1066; author reply 1066-7. doi: 10.1097/ICO.0b013e31820ce2a1. No abstract available.

PMID:
21775886
10.

Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.

Sharma N, Goel M, Bansal S, Agarwal P, Titiyal JS, Upadhyaya AD, Vajpayee RB.

Ophthalmology. 2013 Jun;120(6):1173-8. doi: 10.1016/j.ophtha.2012.11.013. Epub 2013 Feb 15.

PMID:
23415776
11.

Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.

Constantinou M, Daniell M, Snibson GR, Vu HT, Taylor HR.

Ophthalmology. 2007 Sep;114(9):1622-9.

PMID:
17822972
12.

Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.

Alexandrakis G, Alfonso EC, Miller D.

Ophthalmology. 2000 Aug;107(8):1497-502.

PMID:
10919897
13.

Use of adjunctive topical corticosteroids in bacterial keratitis.

Ni N, Srinivasan M, McLeod SD, Acharya NR, Lietman TM, Rose-Nussbaumer J.

Curr Opin Ophthalmol. 2016 Jul;27(4):353-7. doi: 10.1097/ICU.0000000000000273. Review.

PMID:
27096374
14.

Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.

Hyndiuk RA, Eiferman RA, Caldwell DR, Rosenwasser GO, Santos CI, Katz HR, Badrinath SS, Reddy MK, Adenis JP, Klauss V.

Ophthalmology. 1996 Nov;103(11):1854-62; discussion 1862-3.

PMID:
8942881
15.

Besifloxacin in the management of bacterial infections of the ocular surface.

DeschĂȘnes J, Blondeau J.

Can J Ophthalmol. 2015 Jun;50(3):184-91. doi: 10.1016/j.jcjo.2014.12.013. Review.

PMID:
26040217
16.

Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis.

Mallari PL, McCarty DJ, Daniell M, Taylor H.

Am J Ophthalmol. 2001 Jan;131(1):131-3.

PMID:
11162991
17.

Clinical and epidemiological advantages of culturing bacterial keratitis.

Wilhelmus KR, Schlech BA.

Cornea. 2004 Jan;23(1):38-42.

PMID:
14701956
18.

A case of Vibrio vulnificus keratitis.

You IC, Ahn M, Yoon KW, Yoon KC.

Jpn J Ophthalmol. 2008 Mar-Apr;52(2):131-3. doi: 10.1007/s10384-008-0511-4. Epub 2008 Apr 30. No abstract available.

PMID:
18626738
19.

Treating Infectious Keratitis.

Cunningham ET Jr, Acharya NR, Akpek EK, Zierhut M.

Ocul Immunol Inflamm. 2016 Oct;24(5):479-81. doi: 10.1080/09273948.2016.1225473. No abstract available.

PMID:
27681115
20.

Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.

Lee SB, Oliver KM, Strube YN, Mohan SK, Slomovic AR.

Can J Ophthalmol. 2005 Dec;40(6):750-3.

PMID:
16391641

Supplemental Content

Support Center